PGC-1alpha, a new therapeutic target in Huntington's disease?

Cell. 2006 Nov 3;127(3):465-8. doi: 10.1016/j.cell.2006.10.023.

Abstract

The coactivator PGC-1alpha is a key regulator of mitochondrial biogenesis and respiration, mediating expression of several transcription factors required for these programs. Three new studies reveal that PGC-1alpha expression is downregulated in patients with Huntington's disease (HD) and in several animal models of this neurodegenerative disorder, implicating PGC-1alpha in HD pathogenesis and providing a connection between impaired energy metabolism and neurodegeneration.

Publication types

  • Review
  • Comment

MeSH terms

  • Animals
  • Down-Regulation
  • Energy Metabolism
  • Heat-Shock Proteins / genetics
  • Heat-Shock Proteins / metabolism*
  • Humans
  • Huntingtin Protein
  • Huntington Disease / etiology
  • Huntington Disease / metabolism*
  • Huntington Disease / pathology
  • Mice
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / pathology
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Trans-Activators / genetics
  • Trans-Activators / metabolism*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*

Substances

  • HTT protein, human
  • Heat-Shock Proteins
  • Htt protein, mouse
  • Huntingtin Protein
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • PPARGC1A protein, human
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Ppargc1a protein, mouse
  • Trans-Activators
  • Transcription Factors